Enteropathy complicating maintenance therapy in acute lymphoblastic leukaemia

Area of Science:

• Oncology
• Pharmacology
• Gastroenterology

Background:

• Acute lymphoblastic leukaemia (ALL) treatment involves maintenance chemotherapy.
• Chemotherapy can cause significant side effects impacting patient health.
• Gastrointestinal issues are common adverse events in cancer therapy.

Purpose of the Study:

• To investigate the cause of clinical malabsorption in ALL patients.
• To identify potential drug interactions leading to adverse effects.
• To understand the role of specific chemotherapeutic agents in treatment complications.

Main Methods:

• Observational study of seven ALL patients treated between 1976 and 1981.
• Review of patient treatment protocols, including weekly methotrexate and co-trimoxazole.
• Assessment of clinical symptoms, folate levels, and response to therapy cessation.

Main Results:

• Seven patients developed clinical malabsorption during maintenance chemotherapy.
• Five patients exhibited folate deficiency.
• Gastrointestinal symptoms resolved upon discontinuation of anti-leukaemic therapy.

Conclusions:

• Methotrexate and co-trimoxazole combination therapy is postulated to cause malabsorption.
• Folate deficiency may be linked to this drug combination.
• Further research is needed to confirm the synergistic toxicity of these agents.